Masters degree in science in Botany / Medicinal plants or M Pharma pharmacognosy from a recognized University/Institute. Central Council for Research in Homoeopathy
Diploma in Pharmacy / Diploma in Integrated Pharmacy. National Programme for Prevention and Control of Cancer,Diabetes,Cardiovascular Diseases and Stroke - NAM SCHEME
Posses a degree in pharmacy or a diploma in pharmacy of a recognized university or a equivalent educational qualification and must have registered his/her name with the Gujarat pharmacy council.
Masters Degree in Pharmaceutics or Pharmaceutical Sciences from a recognized university. The candidate will be eligible to apply for the Ph.D. position next semester. PhD candidates are encouraged to apply.
MSc Microbiology, Biotechnology, Life Sciences with 60% marks from a UGC-recognized university / institute. CSIR/UGC/ICMR/DBT/GATE or any national-level test score is mandatory.
High academic achievement with first class or equivalent CGPA in B. Sc. & M.Sc. (having experience in relevant area would be given preference Fellowship may be awarded to holders of M.Sc. , M.Sc. (Botany), M.Pharm, and B.Tech (Biotechnology).
First Class Masters Degree in Pharmacology / Life Sciences from a recognized university along with two years research experience or M.Pharma/ MBBS/BDS.
Walk In Interview at Vapi for B.Pharm, BSc, BTech candidates in Bottle, Blister Packing (Primary & Secondary), Skill set of Supervisor, Equipment Qualification.
Responsible for performing the IPQA routine activities such as line clearance, sampling, in process checks etc. Stage wise / online review of documents such as BPR's / Logbooks etc.
Zydus Lifesciences Limited announced its unaudited consolidated financial results for the quarter and half year ended September 30, 2025, showcasing strong growth across all major business segments.
Pfizer Inc. issued a firm response following a ruling by the Court of Chancery of the State of Delaware that denied Pfizers request for a temporary restraining order to block Metsera, Inc. from terminating its merger agreement and accepting a competing proposal from Novo Nordisk A/S.